orphan drug designation IPF
The World’s First AI-Designed Drug Just Got Cleared for Direct-to-Lung Trials in IPF
Idiopathic pulmonary fibrosis kills most patients within three to five years of diagnosis. There is no cure. The two approved treatments slow the scarring but do not stop it, and both carry significant side effects that limit tolerability. Rentosertib was designed by an AI. Not assisted by an AI. Designed by one, from target identification…
